AI assistance raised detection rates of actionable lung nodules on LDCT but did not reduce interpretation time for radiologists.
Key Details
- 1911 asymptomatic adults received LDCT exams, randomized to AI-assisted (n=447) or standard (n=464) interpretation.
- 2Commercial AI tool (Aview Lung Nodule CAD, Coreline Soft) used for nodule identification, classification, and measurement.
- 3AI group detected significantly more Lung-RADS-positive nodules (16.9% vs. 10.3%, p=0.03) and all nodules (52.9% vs. 32.6%, p=0.002).
- 4Interpretation time was not reduced with AI (187s with AI vs. 172s without AI, p=0.23).
- 5AI group had higher frequency of follow-up LDCT recommendations (15.3% vs. 7.4%, p=0.04).
- 6No individual in either group developed lung cancer during median follow-up.
Why It Matters
While AI integration increased detection of clinically relevant findings, it did not improve workflow efficiency and increased follow-up imaging, raising questions about the real-world value and resource implications of AI in lung screening protocols.
Source
AuntMinnie
Related News
•AuntMinnie
AI Advances in Breast Cancer Risk, CEUS Training Updates, and Imaging AI Variability
This week's top radiology news reviews AI advances in breast and lung cancer risk prediction, new CEUS training standards, and prostate screening updates with imaging modalities.
•AuntMinnie
Specialized AI Model Achieves 99% Accuracy in Cardiac MRI Interpretation
A cardiac MRI-specific AI algorithm, CMR-CLIP, demonstrated up to 99% accuracy for certain heart conditions, outperforming general AI models by up to 45.5%.
•Radiology Business
DeepHealth's Prostate AI Gains FDA Clearance for MRI Workflows
DeepHealth, a RadNet subsidiary, received FDA clearance for its AI solution to assist prostate cancer detection and MRI workflow.